f the health care sector. We are already seeing a wave of initial applications, products and pioneering companies, some of which we have co-funded. The DST Healthcare Fund (the "Fund") is not funding traditional drug, diagnostic and device discovery and development opportunities. Instead, the Fund is focused on activel